Researchers from Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.
Oxford University has been ranked as the world's best institution for clinical and health teaching and research for the twelfth consecutive year in the latest Times Higher Education World University Rankings.
The UK\u2019s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium \u2013 in which the University of Oxford is a key partner \u2013 working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.
Professor Christopher Fairburn has been awarded the 2022 American Psychological Association (APA) Award for Distinguished Scientific Applications of Psychology.
New research led from the Nuffield Department of Primary Care Health Sciences has shown that, overall, the average salt content of food products sold at supermarkets has not changed between 2015 and 2020. \r\nThe results also showed that for certain products (ready meals, pizzas and soups) the volume of salt sold increased during this time.
Dr Lennard Lee, academic clinical lecturer at the Department of Oncology was recognised as part of the InterAcademy Partnership Young Physician Leaders Programme 2022
COVID-19 has caused a protracted shock to life expectancy levels, leading to global mortality changes unprecedented in the last 70 years, according to research published in Nature Human Behaviour from Oxford\u2019s Leverhulme Centre for Demographic Science and the Max Planck Institute for Demographic Research.
A new online Postgraduate Diploma in Global Health Research, the first of its kind at Oxford, will offer researchers and clinicians in low-income countries the opportunity to access Oxford\u2019s world-leading teaching, removing the barrier of travel to drive equity in where health research happens.
Health and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
Researchers from the University of Oxford have today reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines \u2013 identifying a particular gene associated with a high antibody response.
Monkeypox virus can be shed into the surrounding environment by people who are infected, particularly in shed skin particles and in debris from monkeypox skin lesions and scabs. The virus is relatively hardy and under appropriate conditions can remain infectious on surfaces for weeks, creating a potential infection risk to others.
A University of Oxford team has been awarded a grant to study one of the major unsolved questions about asthma \u2013 why women are more likely to have it than men and why they are twice as likely to die from it.
Cancer Research UK has today announced the appointment of Professor Ketan (KJ) Patel FRS FMedSci (Radcliffe Department of Medicine) as its new Chief Scientist.
Researchers from the Department of Physiology, Anatomy and Genetics (DPAG) engaged hundreds of visitors at Wesley Memorial Church on Saturday 8 October 2022 as part of The Oxford Science and Ideas Festival\u2019s Explorazone.
Researchers from the University of Oxford have today reported findings from a large-scale study that examined the impact of the UK\u2019s MenACWY vaccination programme on the carriage of meningitis bacteria in the throats of UK teenagers. They have demonstrated the impact of the vaccine in generating herd protection, also called herd immunity, that protects all age groups.
Last month the Oxford Innovation Society (OIS) hosted an event at Pembroke College which celebrated some of the pioneering translational research and innovation coming out of the University\u2019s Medical Sciences Division.
A new study led by Oxford researchers found that prior COVID-19 infection was associated with more uneven inflation of the lungs during normal breathing, smaller lung volumes, and greater respiratory dead space.
Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.
![\"Vials](\"https://www.medsci.ox.ac.uk/news/study-reveals-new-evidence-on-rare-blood-clotting-condition-after-covid-19-vaccination/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n